Login / Signup

The E3 ubiquitin ligase Itch restricts antigen-driven B cell responses.

Emily K MoserJennifer RoofJoseph M DybasLynn A SpruceSteven H SeeholzerMichael P CancroPaula M Oliver
Published in: The Journal of experimental medicine (2019)
The E3 ubiquitin ligase Itch regulates antibody levels and prevents autoimmune disease in humans and mice, yet how Itch regulates B cell fate or function is unknown. We now show that Itch directly limits B cell activity. While Itch-deficient mice displayed normal numbers of preimmune B cell populations, they showed elevated numbers of antigen-experienced B cells. Mixed bone marrow chimeras revealed that Itch acts within B cells to limit naive and, to a greater extent, germinal center (GC) B cell numbers. B cells lacking Itch exhibited increased proliferation, glycolytic capacity, and mTORC1 activation. Moreover, stimulation of these cells in vivo by WT T cells resulted in elevated numbers of GC B cells, PCs, and serum IgG. These results support a novel role for Itch in limiting B cell metabolism and proliferation to suppress antigen-driven B cell responses.
Keyphrases
  • atopic dermatitis
  • bone marrow
  • signaling pathway
  • induced apoptosis
  • mesenchymal stem cells
  • oxidative stress
  • adipose tissue
  • cell proliferation
  • skeletal muscle
  • insulin resistance